Benitec Biopharma Income Statement (2019-2025) | BNTC

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Revenue & cost
Revenue 0.03M0.08M0.03M-0.04M0.06M0.00M0.00M0.00M0.03M0.05M0.01M0.05M0.01M
Gross Profit 0.01M-0.23M-0.02M0.01M-0.08M-0.02M-0.01M0.00M
Operating items
Research & Development 0.42M0.60M0.81M0.91M0.77M1.17M2.76M2.32M2.78M3.15M2.17M3.18M2.66M3.76M3.17M3.19M4.43M5.10M2.57M3.51M3.58M5.38M6.50M2.87M
Selling, General & Administrative 0.75M1.90M1.29M1.90M1.84M2.11M1.03M1.54M2.04M1.71M1.34M1.55M1.92M1.86M1.23M1.37M1.55M1.82M1.58M2.04M2.21M5.42M8.84M6.97M
Other Operating Expenses 0.03M-0.31M0.05M0.05M0.13M-0.02M0.01M0.00M0.01M-0.11M0.00M-0.00M
Operating Expenses 1.20M2.19M2.14M2.85M2.75M3.26M3.79M3.86M4.82M4.86M3.51M4.74M4.58M5.62M4.39M4.56M5.87M6.93M4.14M5.55M5.79M10.80M15.34M9.83M
Operating Income -1.17M-2.11M-2.11M-2.89M-2.69M-3.26M-3.79M-3.85M-4.82M-4.83M-3.46M-4.74M-4.58M-5.61M-4.34M-4.55M-5.87M-6.93M-4.14M-5.55M-5.79M-10.80M-15.34M-9.83M
EBIT -1.17M-2.11M-2.11M-2.89M-2.69M-3.26M-3.79M-3.85M-4.82M-4.83M-3.46M-4.74M-4.58M-5.61M-4.34M-4.55M-5.87M-6.93M-4.14M-5.55M-5.79M-10.80M-15.34M-9.83M
Non-operating items
Non Operating Investment Income 0.00M-0.00M-0.00M-0.00M0.02M0.02M-0.02M-0.01M-0.00M0.00M-0.00M-0.00M0.00M-0.00M
Interest & Investment Income 0.02M0.02M0.02M0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M0.92M0.60M0.82M0.82M1.04M
Other Non Operating Income 0.01M-0.01M-0.09M-0.05M0.01M-0.11M-0.17M-0.24M0.05M0.23M-0.27M-0.51M0.16M-0.04M-0.02M-0.06M0.15M-0.12M-0.15M0.09M0.76M0.01M
Non Operating Income 0.02M0.02M0.01M-0.02M-0.03M0.01M-0.12M-0.15M-0.22M0.01M0.18M-0.33M-0.51M0.20M-0.06M-0.11M-0.08M0.13M-0.14M0.83M0.73M1.25M0.83M1.03M
Net income details
EBT -1.15M-2.09M-2.10M-2.88M-2.69M-3.26M-3.79M-3.86M-4.82M-4.85M-3.47M-4.75M-4.59M-5.62M-4.35M-4.56M-5.88M-6.93M-4.14M-4.63M-5.19M-9.98M-14.51M-8.80M
Profit After Tax -1.15M-2.09M-2.10M-2.96M-2.72M-3.25M-3.91M-4.00M-5.04M-4.82M-3.27M-5.07M-5.10M-5.41M-4.40M-4.70M-6.00M-6.80M-4.28M-4.77M-5.10M-9.55M-14.50M-8.80M
Income from Continuing Operations -1.15M-2.09M-2.10M-2.88M-2.69M-3.26M-3.79M-3.86M-4.82M-4.85M-3.47M-4.75M-4.59M-5.62M-4.35M-4.56M-5.88M-6.93M-4.14M-4.63M-5.19M-9.98M-14.51M-8.80M
Consolidated Net Income -1.15M-2.09M-2.10M-2.88M-2.69M-3.26M-3.79M-3.86M-4.82M-4.85M-3.47M-4.75M-4.59M-5.62M-4.35M-4.56M-5.88M-6.93M-4.14M-4.63M-5.19M-9.98M-14.51M-8.80M
Income towards Parent Company -1.15M-2.09M-2.10M-2.88M-2.69M-3.26M-3.79M-3.86M-4.82M-4.85M-3.47M-4.75M-4.59M-5.62M-4.35M-4.56M-5.88M-6.93M-4.14M-4.63M-5.19M-9.98M-14.51M-8.80M
Preferred Dividend Payments 0.62M618.99M
Net Income towards Common Stockholders -1.15M-2.09M-2.10M-2.88M-2.69M-3.26M-3.79M-3.86M-4.82M-4.85M-3.47M-4.75M-4.59M-5.62M-4.35M-4.56M-6.57M-6.80M-4.28M-4.72M-5.06M-9.55M-14.50M-8.80M
Additional items
EPS (Basic) -1.34-2.00-1.96-2.74-2.45-0.76-0.82-0.30-0.62-0.59-0.40-36.27-7.98-3.34-2.67-2.65-3.05-2.64-0.23-0.11-0.18-0.26-0.38-0.21
EPS (Weighted Average and Diluted) -0.90-0.62-0.59-0.40-36.27-7.98-3.34-2.67-2.65-3.05-2.64-0.23-0.11-0.18-0.26-0.38-0.21
Shares Outstanding (Weighted Average) 0.08M0.08M0.08M0.08M0.08M0.07M0.27M0.27M0.46M0.48M0.48M0.48M0.48M0.48M1.65M1.65M1.65M2.55M2.57M2.59M9.37M10.56M23.22M23.45M25.60M
Shares Outstanding (Diluted Average) 4.30M8.17M8.17M8.17M0.48M0.64M1.62M1.65M1.39M2.16M2.58M18.28M18.36M27.88M37.25M38.60M
EBITDA -1.45M-1.75M-3.00M-2.15M-2.54M-3.04M-3.93M-3.87M-4.81M-4.88M-3.51M-4.81M-4.59M-5.57M-4.35M-4.64M-5.90M-6.97M-4.16M-4.78M-5.16M-9.25M-14.53M-8.93M
Shares Outstanding 0.86M1.04M1.07M1.07M1.11M1.11M4.54M4.82M0.48M8.17M8.17M8.17M0.51M1.52M1.65M1.65M1.67M2.55M2.59M2.72M10.09M17.89M23.45M25.55M